BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 27266617)

  • 1. Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.
    Ye D; Yang K; Zang S; Lin Z; Chau HT; Wang Y; Zhang J; Shi J; Xu A; Lin S; Wang Y
    J Hepatol; 2016 Nov; 65(5):988-997. PubMed ID: 27266617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease.
    Wieser V; Tymoszuk P; Adolph TE; Grander C; Grabherr F; Enrich B; Pfister A; Lichtmanegger L; Gerner R; Drach M; Moser P; Zoller H; Weiss G; Moschen AR; Theurl I; Tilg H
    J Hepatol; 2016 Apr; 64(4):872-80. PubMed ID: 26682726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
    Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
    J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice.
    Kim KE; Lee J; Shin HJ; Jeong EA; Jang HM; Ahn YJ; An HS; Lee JY; Shin MC; Kim SK; Yoo WG; Kim WH; Roh GS
    Hepatology; 2023 Mar; 77(3):888-901. PubMed ID: 35560370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
    Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
    J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-22 Ameliorates Neutrophil-Driven Nonalcoholic Steatohepatitis Through Multiple Targets.
    Hwang S; He Y; Xiang X; Seo W; Kim SJ; Ma J; Ren T; Park SH; Zhou Z; Feng D; Kunos G; Gao B
    Hepatology; 2020 Aug; 72(2):412-429. PubMed ID: 31705800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
    Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
    Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis.
    Xu G; Wang YM; Ying MM; Chen SD; Li ZR; Ma HL; Zheng MH; Wu J; Ding C
    Clin Mol Hepatol; 2021 Apr; 27(2):329-345. PubMed ID: 33465844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective and Detrimental Roles of p38α Mitogen-Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease.
    Hwang S; Wang X; Rodrigues RM; Ma J; He Y; Seo W; Park SH; Kim SJ; Feng D; Gao B
    Hepatology; 2020 Sep; 72(3):873-891. PubMed ID: 32463484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pivotal role played by lipocalin-2 in chronic inflammatory pain.
    Jha MK; Jeon S; Jin M; Ock J; Kim JH; Lee WH; Suk K
    Exp Neurol; 2014 Apr; 254():41-53. PubMed ID: 24440229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils Play a Crucial Role in the Early Stage of Nonalcoholic Steatohepatitis via Neutrophil Elastase in Mice.
    Zang S; Wang L; Ma X; Zhu G; Zhuang Z; Xun Y; Zhao F; Yang W; Liu J; Luo Y; Liu Y; Ye D; Shi J
    Cell Biochem Biophys; 2015 Nov; 73(2):479-487. PubMed ID: 27352342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity.
    Chen L; Gu J; Qian Y; Li M; Qian Y; Xu M; Li J; Wen Y; Xia L; Li J; Xia Q; Kong X; Wu H
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):623-639. PubMed ID: 30630119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β
    Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
    J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH.
    Tran M; Lee SM; Shin DJ; Wang L
    JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
    J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake.
    Hwang S; Ren T; Gao B
    Clin Mol Hepatol; 2020 Oct; 26(4):586-594. PubMed ID: 32937687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.
    Tosello-Trampont AC; Landes SG; Nguyen V; Novobrantseva TI; Hahn YS
    J Biol Chem; 2012 Nov; 287(48):40161-72. PubMed ID: 23066023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
    Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
    J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.